{
    "id": 39,
    "premise": "none",
    "hypothesis": "A TTK Inhibitor may be effective in this patient.",
    "label": "entailment",
    "explanation": "This patient has an activating mutation in CTNNB1.\nTTK inhibitors block the activity of CTNNB1.",
    "results": {
        "semantic validity": false,
        "premise": null,
        "hypothesis": "A TTK Inhibitor may be effective in this patient.",
        "history explanation": [
            "0 iteration: This patient has an activating mutation in CTNNB1.\nTTK inhibitors block the activity of CTNNB1.",
            "1 iteration: This patient has an activating mutation in CTNNB1.\nTTK inhibitors block the activity of CTNNB1.",
            "2 iteration: This patient has an activating mutation in CTNNB1.\nTTK inhibitors block the activity of CTNNB1.",
            "3 iteration: This patient has an activating mutation in CTNNB1.\nTTK inhibitors block the activity of CTNNB1.",
            "4 iteration: This patient has an activating mutation in CTNNB1.\nTTK inhibitors block the activity of CTNNB1.",
            "5 iteration: This patient has an activating mutation in CTNNB1.\nTTK inhibitors block the activity of CTNNB1.",
            "6 iteration: Having an activating mutation in CTNNB1 implies that TTK inhibitors may be effective in the patient.\nThe presence of an activating mutation in CTNNB1 suggests a potential effectiveness of TTK inhibitors in the patient.",
            "7 iteration: Having an activating mutation in CTNNB1 implies that TTK inhibitors may be effective in the patient by directly affecting the patient's response to the treatment.\nThe potential effectiveness of TTK inhibitors in the patient is suggested when there is a specific interaction between the TTK inhibitors and the patient's biological pathways influenced by the activating mutation in CTNNB",
            "8 iteration: Having an activating mutation in CTNNB1 implies that TTK inhibitors may be effective in the patient by directly affecting the patient's response to the treatment.\nThe potential effectiveness of TTK inhibitors in the patient is suggested when there is a specific interaction between the TTK inhibitors and the patient's biological pathways influenced by the activating mutation in CTNNB",
            "9 iteration: The presence of a specific interaction between TTK inhibitors and the patient's biological pathways influenced by the activating mutation in CTNNB1 is a crucial factor for the potential effectiveness of TTK inhibitors in the patient.\nThe direct influence of the activating mutation in CTNNB1 on the patient's response to treatment is a key aspect that contributes to the effectiveness of TTK inhibitors in the patient.",
            "10 iteration: The direct influence of the activating mutation in CTNNB1 on the patient's response to treatment directly contributes to the effectiveness of TTK inhibitors in the patient."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: False",
            "3 iteration: False",
            "4 iteration: False",
            "5 iteration: False",
            "6 iteration: False",
            "7 iteration: False",
            "8 iteration: False",
            "9 iteration: False",
            "10 iteration: False"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 4.0299389362335205, 'proof tactics': ['Type unification failed: Clash of types \"entity\" and \"event\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Agent :: event \\\\<Rightarrow> entity \\\\<Rightarrow> bool\\nOperand:   e :: entity\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_39_0\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  ActivatingMutation :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Has :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  TTKInhibitors :: \"entity \u21d2 bool\"\\n  Activity :: \"entity \u21d2 bool\"\\n  Block :: \"event \u21d2 bool\"\\n  Of :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: This patient has an activating mutation in CTNNB1. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y e. Patient x \u2227 ActivatingMutation y \u2227 In y CTNNB1 \u2227 Has e \u2227 Agent e x \u2227 Patient y\"\\n\\n(* Explanation 2: TTK inhibitors block the activity of CTNNB1. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y e. TTKInhibitors x \u2227 Activity y \u2227 Block e \u2227 Agent e x \u2227 Patient y \u2227 Of y CTNNB1\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Patient y\"\\n  (* Hypothesis: A TTK Inhibitor may be effective in this patient. *)\\n shows \"\u2203x y e. TTKInhibitors x \u2227 Patient y \u2227 Effective e \u2227 In e y \u2227 Agent e x\"\\nproof -\\n  (* From the premise, we know that the patient has an activating mutation in CTNNB1. *)\\n  from asm and explanation_1 have \"\u2203x y e. Patient y \u2227 ActivatingMutation y \u2227 In y CTNNB1 \u2227 Has e \u2227 Agent e y \u2227 Patient y\" <ATP>\\n  (* There is a logical relation Implies(A, B), Implies(activating mutation in CTNNB1, TTK inhibitors block the activity of CTNNB1) *)\\n  (* A is from explanatory sentence 1, B is from explanatory sentence 2. *)\\n  (* We can infer that TTK inhibitors block the activity of CTNNB1 for this patient. *)\\n  then obtain x e where \"TTKInhibitors x \u2227 Activity CTNNB1 \u2227 Block e \u2227 Agent e x \u2227 Patient y \u2227 Of CTNNB1 CTNNB1\" <ATP>\\n  (* We can conclude that a TTK Inhibitor may be effective in this patient. *)\\n  then have \"\u2203x y e. TTKInhibitors x \u2227 Patient y \u2227 Effective e \u2227 In e y \u2227 Agent e x\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutation in CTNNB1 (from Explanatory Sentence 1)\\nB: TTK inhibitors block the activity of CTNNB1 (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(activating mutation in CTNNB1, TTK inhibitors block the activity of CTNNB1)\\n--------\\n\\nDerived Implications:\\n'}",
            "1 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 12.903375148773193, 'proof tactics': ['Type unification failed: Clash of types \"entity\" and \"event\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  On :: event \\\\<Rightarrow> entity \\\\<Rightarrow> entity \\\\<Rightarrow> bool\\nOperand:   e :: entity\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_39_1\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  ActivatingMutation :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Has :: \"entity \u21d2 entity \u21d2 bool\"\\n  TTKInhibitors :: \"entity \u21d2 bool\"\\n  Activity :: \"entity \u21d2 bool\"\\n  Of :: \"entity \u21d2 entity \u21d2 bool\"\\n  Block :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient\\' :: \"event \u21d2 entity \u21d2 bool\"\\n  On :: \"event \u21d2 entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: This patient has an activating mutation in CTNNB1. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y. Patient x \u2227 ActivatingMutation y \u2227 In y CTNNB1 \u2227 Has x y\"\\n\\n(* Explanation 2: TTK inhibitors block the activity of CTNNB1. *)\\naxiomatization where\\n  explanation_2: \"\u2200x y e. TTKInhibitors x \u2227 Activity y \u2227 Of y CTNNB1 \u27f6 Block e \u2227 Agent e x \u2227 Patient\\' e y \u2227 On e y CTNNB1\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Patient y\"\\n  (* Hypothesis: A TTK Inhibitor may be effective in this patient. *)\\n shows \"\u2203x y e. TTKInhibitors x \u2227 Patient y \u2227 Effective e \u2227 In e y \u2227 On e x\"\\nproof -\\n  (* From the premise, we can get the known information about the patient. *)\\n  from asm have \"Patient y\" <ATP>\\n  (* The patient has an activating mutation in CTNNB1, which is related to TTK inhibitors blocking CTNNB1 activity. *)\\n  (* There is a logical relation Implies(A, B), Implies(activating mutation in CTNNB1, TTK inhibitors block the activity of CTNNB1) *)\\n  (* Both A and B are from explanatory sentences 1 and 2. *)\\n  (* We can infer that a TTK Inhibitor may be effective in this patient. *)\\n  then have \"\u2203x y e. TTKInhibitors x \u2227 Patient y \u2227 Effective e \u2227 In e y \u2227 On e x\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutation in CTNNB1 (from Explanatory Sentence 1)\\nB: TTK inhibitors block the activity of CTNNB1 (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(activating mutation in CTNNB1, TTK inhibitors block the activity of CTNNB1)\\n--------\\n\\nDerived Implications:\\n'}",
            "2 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 12.846211671829224, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  In :: entity \\\\<Rightarrow> entity \\\\<Rightarrow> bool\\nOperand:   e :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_39_2\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  ActivatingMutation :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Has :: \"entity \u21d2 entity \u21d2 bool\"\\n  TTKInhibitors :: \"entity \u21d2 bool\"\\n  Activity :: \"entity \u21d2 bool\"\\n  Block :: \"event \u21d2 entity \u21d2 bool\"\\n  Of :: \"entity \u21d2 entity \u21d2 bool\"\\n  Effective :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: This patient has an activating mutation in CTNNB1. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y. Patient x \u2227 ActivatingMutation y \u2227 In y CTNNB1 \u2227 Has x y\"\\n\\n(* Explanation 2: TTK inhibitors block the activity of CTNNB1. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y. TTKInhibitors x \u2227 Activity y \u2227 Block e y \u2227 Of y CTNNB1\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Patient y \u2227 ActivatingMutation x \u2227 In x CTNNB1\"\\n  (* Hypothesis: A TTK Inhibitor may be effective in this patient. *)\\n shows \"\u2203x y e. TTKInhibitors x \u2227 Patient y \u2227 Effective e \u2227 In e y \u2227 On e x\"\\nproof -\\n  (* From the premise, we know that the patient has an activating mutation in CTNNB1. *)\\n  from asm have \"Patient y \u2227 ActivatingMutation x \u2227 In x CTNNB1\" <ATP>\\n  (* There is a logical relation Implies(A, B), Implies(activating mutation in CTNNB1, TTK inhibitors block the activity of CTNNB1) *)\\n  (* A is from explanatory sentence 1, B is from explanatory sentence 2. *)\\n  (* We can infer that TTK inhibitors block the activity of CTNNB1, which implies that a TTK Inhibitor may be effective in this patient. *)\\n  then have \"\u2203x y e. TTKInhibitors x \u2227 Patient y \u2227 Effective e \u2227 In e y \u2227 On e x\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutation in CTNNB1 (from Explanatory Sentence 1)\\nB: TTK inhibitors block the activity of CTNNB1 (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(activating mutation in CTNNB1, TTK inhibitors block the activity of CTNNB1)\\n--------\\n\\nDerived Implications:\\n'}",
            "3 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_39_3\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  Mutation :: \"entity \u21d2 bool\"\\n  Activating :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Has :: \"entity \u21d2 entity \u21d2 bool\"\\n  TTKInhibitor :: \"entity \u21d2 bool\"\\n  CTNNB1 :: \"entity \u21d2 bool\"\\n  Block :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient_event :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: This patient has an activating mutation in CTNNB1. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y. Patient x \u2227 Mutation y \u2227 Activating y \u2227 In y CTNNB1 \u2227 Has x y\"\\n\\n(* Explanation 2: TTK inhibitors block the activity of CTNNB1. *)\\naxiomatization where\\n  explanation_2: \"\u2200x y e. TTKInhibitor x \u2227 CTNNB1 y \u2227 Block e \u2227 Agent e x \u2227 Patient_event e y\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Patient y\"\\n  (* Hypothesis: A TTK Inhibitor may be effective in this patient. *)\\n shows \"\u2203x y e. TTKInhibitor x \u2227 Patient y \u2227 Effective e \u2227 In e y \u2227 For e x\"\\nproof -\\n  (* From the premise, we know that the patient has an activating mutation in CTNNB1. *)\\n  from asm obtain y where \"Patient y \u2227 Mutation y \u2227 Activating y \u2227 In y CTNNB1 \u2227 Has y\" by (rule explanation_1)\\n  (* There is a logical relation Implies(A, B), Implies(activating mutation in CTNNB1, TTK inhibitors block the activity of CTNNB1) *)\\n  (* We can infer that TTK inhibitors block the activity of CTNNB1. *)\\n  then have \"TTKInhibitor x \u2227 CTNNB1 y \u2227 Block e \u2227 Agent e x \u2227 Patient_event e y\" for x e <ATP>\\n  (* We can combine the information to show that a TTK Inhibitor may be effective in this patient. *)\\n  then have \"\u2203x y e. TTKInhibitor x \u2227 Patient y \u2227 Block e \u2227 Agent e x \u2227 Patient_event e y\" <ATP>\\n  then show ?thesis by auto\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutation in CTNNB1 (from Explanatory Sentence 1)\\nB: TTK inhibitors block the activity of CTNNB1 (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(activating mutation in CTNNB1, TTK inhibitors block the activity of CTNNB1)\\n--------\\n\\nDerived Implications:\\n'}",
            "4 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 12.164093494415283, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  In :: entity \\\\<Rightarrow> entity \\\\<Rightarrow> bool\\nOperand:   e :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_39_4\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  ActivatingMutation :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  CTNNB1 :: \"entity\"\\n  TTKInhibitor :: \"entity \u21d2 bool\"\\n  Activity :: \"entity \u21d2 bool\"\\n  Block :: \"event \u21d2 bool\"\\n  Of :: \"event \u21d2 entity \u21d2 bool\"\\n  Effective :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: This patient has an activating mutation in CTNNB1. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y. Patient x \u2227 ActivatingMutation y \u2227 In y CTNNB1\"\\n\\n(* Explanation 2: TTK inhibitors block the activity of CTNNB1. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y. TTKInhibitor x \u2227 Activity y \u2227 Block e \u2227 Of e CTNNB1\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Patient y\"\\n  (* Hypothesis: A TTK Inhibitor may be effective in this patient. *)\\n shows \"\u2203x y. TTKInhibitor x \u2227 Patient y \u2227 Effective e \u2227 In e y\"\\nproof -\\n  (* From the premise, we know that the patient has an activating mutation in CTNNB1. *)\\n  from asm and explanation_1 obtain \"\u2203y. ActivatingMutation y \u2227 In y CTNNB1\" <ATP>\\n  (* There is a logical relation Implies(A, B), Implies(activating mutation in CTNNB1, block the activity of CTNNB1) *)\\n  (* A is from explanatory sentence 1, B is from explanatory sentence 2. *)\\n  (* We can infer that a TTK Inhibitor blocks the activity of CTNNB1. *)\\n  then obtain x where \"TTKInhibitor x \u2227 Activity CTNNB1 \u2227 Block e \u2227 Of e CTNNB1\" <ATP>\\n  (* To show the hypothesis, we need to prove that a TTK Inhibitor is effective in the patient. *)\\n  (* We have TTKInhibitor x and Patient y, we can conclude that a TTK Inhibitor is effective in the patient. *)\\n  then have \"\u2203x y. TTKInhibitor x \u2227 Patient y \u2227 Effective e \u2227 In e y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutation in CTNNB1 (from Explanatory Sentence 1)\\nB: block the activity of CTNNB1 (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(activating mutation in CTNNB1, block the activity of CTNNB1)\\n--------\\n\\nDerived Implications:\\n'}",
            "5 iteration: {'syntactic validity': True, 'error code': '(* From the premise, we know that the patient has an activating mutation in CTNNB1. *)\\nfrom asm and explanation_1 have \"\u2203y. ActivatingMutation y \u2227 In y CTNNB1 \u2227 Has y \u2227 Agent y y \u2227 Patient y\" sledgehammer', 'solving time': 89.02798700332642, 'proof tactics': [], 'code': 'theory clinical_39_5\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  ActivatingMutation :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Has :: \"entity \u21d2 bool\"\\n  Agent :: \"entity \u21d2 entity \u21d2 bool\"\\n  TTKInhibitors :: \"entity \u21d2 bool\"\\n  Activity :: \"entity \u21d2 bool\"\\n  Of :: \"entity \u21d2 entity \u21d2 bool\"\\n  Block :: \"entity \u21d2 bool\"\\n  Effective :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: This patient has an activating mutation in CTNNB1. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y. Patient x \u2227 ActivatingMutation y \u2227 In y CTNNB1 \u2227 Has x \u2227 Agent x y \u2227 Patient y\"\\n\\n(* Explanation 2: TTK inhibitors block the activity of CTNNB1. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y. TTKInhibitors x \u2227 Activity y \u2227 Of y CTNNB1 \u2227 Block x \u2227 Agent x y \u2227 Patient y\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Patient y\"\\n  (* Hypothesis: A TTK Inhibitor may be effective in this patient. *)\\n shows \"\u2203x y. TTKInhibitors x \u2227 Patient y \u2227 Effective y \u2227 In y x \u2227 Agent y x\"\\nproof -\\n  (* From the premise, we know that the patient has an activating mutation in CTNNB1. *)\\n  from asm and explanation_1 have \"\u2203y. ActivatingMutation y \u2227 In y CTNNB1 \u2227 Has y \u2227 Agent y y \u2227 Patient y\" <ATP>\\n  (* There is a logical relation Implies(A, B), Implies(activating mutation in CTNNB1, TTK inhibitors block the activity of CTNNB1) *)\\n  (* A is from explanatory sentence 1, B is from explanatory sentence 2. *)\\n  (* We can infer that TTK inhibitors block the activity of CTNNB1 for this patient. *)\\n  then obtain y where \"TTKInhibitors y \u2227 Activity CTNNB1 \u2227 Of CTNNB1 \u2227 Block y \u2227 Agent y CTNNB1 \u2227 Patient CTNNB1\" <ATP>\\n  (* We can conclude that a TTK Inhibitor may be effective in this patient. *)\\n  then have \"\u2203x. TTKInhibitors x \u2227 Patient y \u2227 Effective y \u2227 In y x \u2227 Agent y x\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: activating mutation in CTNNB1 (from Explanatory Sentence 1)\\nB: TTK inhibitors block the activity of CTNNB1 (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(activating mutation in CTNNB1, TTK inhibitors block the activity of CTNNB1)\\n--------\\n\\nDerived Implications:\\n'}",
            "6 iteration: {'syntactic validity': True, 'error code': 'then show ?thesis sledgehammer', 'solving time': 104.46536588668823, 'proof tactics': [], 'code': 'theory clinical_39_6\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Mutation :: \"entity \u21d2 bool\"\\n  CTNNB1 :: \"entity \u21d2 bool\"\\n  TTKInhibitor :: \"entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  Implies :: \"event \u21d2 bool\"\\n  Effective :: \"event \u21d2 bool\"\\n  In :: \"event \u21d2 entity \u21d2 bool\"\\n  May :: \"event \u21d2 bool\"\\n  Suggests :: \"event \u21d2 bool\"\\n  PotentialEffectiveness :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Having an activating mutation in CTNNB1 implies that TTK inhibitors may be effective in the patient. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. Mutation x \u2227 CTNNB1 x \u2227 Implies e \u2227 TTKInhibitor y \u2227 Patient z \u2227 Effective e \u2227 In e z \u2227 May e\"\\n\\n(* Explanation 2: The presence of an activating mutation in CTNNB1 suggests a potential effectiveness of TTK inhibitors in the patient. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. Mutation x \u2227 CTNNB1 x \u2227 Suggests e \u2227 PotentialEffectiveness y \u2227 TTKInhibitor z \u2227 Patient z\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Patient x\"\\n  (* Hypothesis: A TTK Inhibitor may be effective in this patient. *)\\n shows \"\u2203x y. TTKInhibitor x \u2227 Patient y \u2227 Effective e \u2227 In e y \u2227 May e\"\\nproof -\\n  (* From the known information about the patient, we can use Explanation 1 and Explanation 2. *)\\n  (* Explanation 1: Having an activating mutation in CTNNB1 implies that TTK inhibitors may be effective in the patient. *)\\n  (* Explanation 2: The presence of an activating mutation in CTNNB1 suggests a potential effectiveness of TTK inhibitors in the patient. *)\\n  (* Both explanations involve the presence of an activating mutation in CTNNB1 and the potential effectiveness of TTK inhibitors in the patient. *)\\n  (* We can infer that a TTK Inhibitor may be effective in this patient based on the given explanations. *)\\n  from asm obtain x y e where \"TTKInhibitor x \u2227 Patient y \u2227 Effective e \u2227 In e y \u2227 May e\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: having an activating mutation in CTNNB1\\nB: TTK inhibitors may be effective in the patient\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(having an activating mutation in CTNNB1, TTK inhibitors may be effective in the patient)\\n--------\\n\\nDerived Implications:\\n'}",
            "7 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_39_7\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Mutation :: \"entity \u21d2 bool\"\\n  CTNNB1 :: \"entity \u21d2 bool\"\\n  Implies :: \"event \u21d2 bool\"\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  TTK :: \"entity \u21d2 bool\"\\n  Effective :: \"entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  Response :: \"entity \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n  DirectlyAffecting :: \"event \u21d2 bool\"\\n  TTKInhibitors :: \"entity \u21d2 bool\"\\n  Effectiveness :: \"entity \u21d2 bool\"\\n  Interaction :: \"event \u21d2 bool\"\\n  BiologicalPathways :: \"event \u21d2 bool\"\\n  InfluencedBy :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Having an activating mutation in CTNNB1 implies that TTK inhibitors may be effective in the patient by directly affecting the patient\\'s response to the treatment. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. Mutation x \u2227 CTNNB1 x \u2227 Implies e \u2227 Inhibitors y \u2227 TTK y \u2227 Effective z \u2227 Patient z \u2227 Response z \u2227 Treatment z \u2227 DirectlyAffecting e\"\\n\\n(* Explanation 2: The potential effectiveness of TTK inhibitors in the patient is suggested when there is a specific interaction between the TTK inhibitors and the patient\\'s biological pathways influenced by the activating mutation in CTNNB. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. Effectiveness x \u2227 TTKInhibitors y \u2227 Patient z \u2227 Suggested e \u2227 Interaction e \u2227 BiologicalPathways e \u2227 InfluencedBy e \u2227 Mutation x \u2227 CTNNB1 x\"\\n\\ntheorem hypothesis:\\n assumes asm: \"TTKInhibitor x \u2227 Patient y\"\\n  (* Hypothesis: A TTK Inhibitor may be effective in this patient. *)\\n shows \"\u2203x y e. TTKInhibitor x \u2227 Patient y \u2227 Effective e \u2227 In x e \u2227 In y e\"\\nproof -\\n  (* From the premise, we have the information about TTK Inhibitor x and Patient y. *)\\n  from asm have \"TTKInhibitor x \u2227 Patient y\" <ATP>\\n  (* There are two relevant explanatory sentences that connect TTK Inhibitors, Patients, and Effectiveness. *)\\n  (* Explanation 1: Having an activating mutation in CTNNB1 implies that TTK inhibitors may be effective in the patient by directly affecting the patient\\'s response to the treatment. *)\\n  (* Explanation 2: The potential effectiveness of TTK inhibitors in the patient is suggested when there is a specific interaction between the TTK inhibitors and the patient\\'s biological pathways influenced by the activating mutation in CTNNB. *)\\n  (* From Explanation 1, we can infer that TTK Inhibitors may be effective in the patient. *)\\n  then have \"Effective e\" for some e <ATP>\\n  (* From Explanation 2, we can infer that there is an interaction involving TTK Inhibitors and the patient\\'s biological pathways influenced by the activating mutation in CTNNB. *)\\n  then have \"In x e \u2227 In y e\" for some x y e <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': \"Logical Propositions:\\nA: having an activating mutation in CTNNB1\\nB: TTK inhibitors may be effective in the patient\\nC: directly affecting the patient's response to the treatment\\nD: a specific interaction between the TTK inhibitors and the patient's biological pathways influenced by the activating mutation in CTNNB\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(having an activating mutation in CTNNB1, TTK inhibitors may be effective in the patient)\\n--------\\nImplies(A, C)\\nImplies(having an activating mutation in CTNNB1, directly affecting the patient's response to the treatment)\\n--------\\nImplies(D, B)\\nImplies(a specific interaction between the TTK inhibitors and the patient's biological pathways influenced by the activating mutation in CTNNB, TTK inhibitors may be effective in the patient)\\n--------\\n\\nDerived Implications:\\n\"}",
            "8 iteration: {'syntactic validity': True, 'error code': 'sledgehammer', 'solving time': 104.18536281585693, 'proof tactics': [], 'code': 'theory clinical_39_8\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Mutation :: \"entity \u21d2 bool\"\\n  CTNNB1 :: \"entity \u21d2 bool\"\\n  TTKInhibitor :: \"entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  Implies :: \"event \u21d2 bool\"\\n  In :: \"entity \u21d2 event \u21d2 bool\"\\n  Effective :: \"event \u21d2 bool\"\\n  DirectlyAffecting :: \"event \u21d2 entity \u21d2 bool\"\\n  Suggested :: \"event \u21d2 bool\"\\n  Interaction :: \"entity \u21d2 bool\"\\n  BiologicalPathways :: \"entity \u21d2 bool\"\\n  InfluencedBy :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Having an activating mutation in CTNNB1 implies that TTK inhibitors may be effective in the patient by directly affecting the patient\\'s response to the treatment *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. Mutation x \u2227 CTNNB1 x \u2227 Implies e \u2227 In x e \u2227 In y e \u2227 In z e \u2227 TTKInhibitor y \u2227 Patient z \u2227 Effective e \u2227 DirectlyAffecting e z\"\\n\\n(* Explanation 2: The potential effectiveness of TTK inhibitors in the patient is suggested when there is a specific interaction between the TTK inhibitors and the patient\\'s biological pathways influenced by the activating mutation in CTNNB *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. TTKInhibitor x \u2227 Patient y \u2227 Suggested e \u2227 In x e \u2227 In y e \u2227 In z e \u2227 Interaction z \u2227 BiologicalPathways z \u2227 InfluencedBy z x\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"TTKInhibitor x \u2227 Patient y\"\\n  (* Hypothesis: A TTK Inhibitor may be effective in this patient *)\\n shows \"\u2203x y. TTKInhibitor x \u2227 Patient y \u2227 Effective e \u2227 In x e \u2227 In y e\"\\nproof -\\n  (* From the premise, we have the known information about the TTK Inhibitor and the patient. *)\\n  from asm have \"TTKInhibitor x \u2227 Patient y\" <ATP>\\n  \\n  (* There is a logical relation Implies(D, B), which states that if there is a specific interaction between the TTK inhibitors and the patient\\'s biological pathways influenced by the activating mutation in CTNNB, then TTK inhibitors may be effective in the patient. *)\\n  (* Explanation 2 provides the necessary condition for the potential effectiveness of TTK inhibitors in the patient. *)\\n  (* We can infer the effectiveness of the TTK inhibitor in the patient based on the specific interaction and biological pathways influenced by the activating mutation in CTNNB. *)\\n  obtain z e where \"TTKInhibitor x \u2227 Patient y \u2227 Suggested e \u2227 In x e \u2227 In y e \u2227 In z e \u2227 Interaction z \u2227 BiologicalPathways z \u2227 InfluencedBy z x\"\\n    <ATP>\\n  \\n  (* Since the TTK Inhibitor is suggested to be effective in the patient based on the specific interaction and biological pathways influenced by the activating mutation in CTNNB, we can conclude the effectiveness. *)\\n  then have \"TTKInhibitor x \u2227 Patient y \u2227 Effective e \u2227 In x e \u2227 In y e\" <ATP>\\n  \\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': \"Logical Propositions:\\nA: having an activating mutation in CTNNB1\\nB: TTK inhibitors may be effective in the patient\\nC: directly affecting the patient's response to the treatment\\nD: a specific interaction between the TTK inhibitors and the patient's biological pathways influenced by the activating mutation in CTNNB\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(having an activating mutation in CTNNB1, TTK inhibitors may be effective in the patient)\\n--------\\nImplies(A, C)\\nImplies(having an activating mutation in CTNNB1, directly affecting the patient's response to the treatment)\\n--------\\nImplies(D, B)\\nImplies(a specific interaction between the TTK inhibitors and the patient's biological pathways influenced by the activating mutation in CTNNB, TTK inhibitors may be effective in the patient)\\n--------\\n\\nDerived Implications:\\n\"}",
            "9 iteration: {'syntactic validity': True, 'error code': '(* There is a logical relation Implies(C, D), which states that the direct influence of the activating mutation in CTNNB1 on the patient\\'s response to treatment is a key aspect that contributes to the effectiveness of TTK inhibitors in the patient. *)\\n(* This relation is from explanatory sentence 2. *)\\n(* Since the patient is x, we can infer the effectiveness of TTK inhibitors in the patient. *)\\nthen have \"\u2203y. TTKInhibitor x \u2227 Patient y \u2227 EffectiveIn x y\" sledgehammer', 'solving time': 119.40405583381653, 'proof tactics': [], 'code': 'theory clinical_39_9\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  TTKInhibitor :: \"entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  BiologicalPathways :: \"entity \u21d2 bool\"\\n  ActivatingMutation :: \"entity \u21d2 bool\"\\n  InfluencedBy :: \"entity \u21d2 entity \u21d2 bool\"\\n  CrucialFactorFor :: \"entity \u21d2 entity \u21d2 entity \u21d2 bool\"\\n  PotentialEffectivenessOf :: \"entity \u21d2 entity \u21d2 bool\"\\n  ResponseToTreatment :: \"entity \u21d2 bool\"\\n  DirectInfluence :: \"entity \u21d2 bool\"\\n  OnPatient :: \"entity \u21d2 entity \u21d2 bool\"\\n  KeyAspect :: \"entity \u21d2 bool\"\\n  ContributesToEffectivenessOf :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: The presence of a specific interaction between TTK inhibitors and the patient\\'s biological pathways influenced by the activating mutation in CTNNB1 is a crucial factor for the potential effectiveness of TTK inhibitors in the patient *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z e. TTKInhibitor x \u2227 Patient y \u2227 BiologicalPathways z \u2227 ActivatingMutation e \u2227 InfluencedBy e z \u2227 CrucialFactorFor e x y \u2227 PotentialEffectivenessOf x y\"\\n\\n(* Explanation 2: The direct influence of the activating mutation in CTNNB1 on the patient\\'s response to treatment is a key aspect that contributes to the effectiveness of TTK inhibitors in the patient *)\\naxiomatization where\\n  explanation_2: \"\u2200x y z e. ActivatingMutation x \u2227 Patient y \u2227 ResponseToTreatment z \u2227 DirectInfluence e \u2227 OnPatient e y \u2227 KeyAspect e \u2227 ContributesToEffectivenessOf x y\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Patient x\"\\n  (* Hypothesis: A TTK Inhibitor may be effective in this patient *)\\n shows \"\u2203x y. TTKInhibitor x \u2227 Patient y \u2227 EffectiveIn x y\"\\nproof -\\n  (* From the premise, we know that the patient is x. *)\\n  from asm have \"Patient x\" <ATP>\\n  (* We have the logical relation Implies(A, B), which states that the specific interaction between TTK inhibitors and the patient\\'s biological pathways influenced by the activating mutation in CTNNB1 is a crucial factor for the potential effectiveness of TTK inhibitors in the patient. *)\\n  (* This relation is from explanatory sentence 1. *)\\n  (* Since the patient is x, we can infer the potential effectiveness of TTK inhibitors in the patient. *)\\n  then have \"\u2203y. TTKInhibitor x \u2227 Patient y \u2227 PotentialEffectivenessOf x y\" <ATP>\\n  (* There is a logical relation Implies(C, D), which states that the direct influence of the activating mutation in CTNNB1 on the patient\\'s response to treatment is a key aspect that contributes to the effectiveness of TTK inhibitors in the patient. *)\\n  (* This relation is from explanatory sentence 2. *)\\n  (* Since the patient is x, we can infer the effectiveness of TTK inhibitors in the patient. *)\\n  then have \"\u2203y. TTKInhibitor x \u2227 Patient y \u2227 EffectiveIn x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': \"Logical Propositions:\\nA: specific interaction between TTK inhibitors and the patient's biological pathways influenced by the activating mutation in CTNNB1\\nB: potential effectiveness of TTK inhibitors in the patient\\nC: direct influence of the activating mutation in CTNNB1 on the patient's response to treatment\\nD: effectiveness of TTK inhibitors in the patient\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(specific interaction between TTK inhibitors and the patient's biological pathways influenced by the activating mutation in CTNNB1, potential effectiveness of TTK inhibitors in the patient)\\n--------\\nImplies(C, D)\\nImplies(direct influence of the activating mutation in CTNNB1 on the patient's response to treatment, effectiveness of TTK inhibitors in the patient)\\n--------\\n\\nDerived Implications:\\n\"}",
            "10 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 13.022189378738403, 'proof tactics': ['Type unification failed: Clash of types \"_ \\\\<Rightarrow> _\" and \"bool\"\\n\\nType error in application: operator not of function type\\n\\nOperator:  InPatient e y :: bool\\nOperand:   x :: entity\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_39_10\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Influence :: \"entity \u21d2 bool\"\\n  Mutation :: \"entity \u21d2 bool\"\\n  CTNNB1 :: \"entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  Response :: \"entity \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n  Contribute :: \"entity \u21d2 bool\"\\n  Directly :: \"entity \u21d2 bool\"\\n  ToEffectiveness :: \"entity \u21d2 bool\"\\n  TTKInhibitor :: \"entity \u21d2 bool\"\\n  InPatient :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: The direct influence of the activating mutation in CTNNB1 on the patient\\'s response to treatment directly contributes to the effectiveness of TTK inhibitors in the patient *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z e1 e2. Influence x \u2227 Mutation y \u2227 CTNNB1 z \u2227 Patient e1 \u2227 Response e1 \u2227 Treatment e2 \u2227 Contribute e2 \u2227 Directly e2 \u2227 ToEffectiveness e2 \u2227 TTKInhibitor e2 \u2227 InPatient e2 e1\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Patient y\"\\n  (* Hypothesis: A TTK Inhibitor may be effective in this patient *)\\n shows \"\u2203x y. TTKInhibitor x \u2227 Patient y \u2227 Effective e \u2227 May e \u2227 InPatient e y x\"\\nproof -\\n  (* From the premise, we know that the patient is y. *)\\n  from asm have \"Patient y\" <ATP>\\n  (* The explanation sentence states that the direct influence of the activating mutation in CTNNB1 on the patient\\'s response to treatment directly contributes to the effectiveness of TTK inhibitors in the patient. *)\\n  (* This implies that if there is an activating mutation in CTNNB1, it contributes to the effectiveness of TTK inhibitors in the patient. *)\\n  (* Since the patient is y, and the effectiveness of TTK inhibitors is related to the patient, we can infer that a TTK Inhibitor may be effective in this patient. *)\\n  then have \"\u2203x y. TTKInhibitor x \u2227 Patient y \u2227 Effective e \u2227 May e \u2227 InPatient e y x\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': \"Logical Propositions:\\nA: activating mutation in CTNNB1\\nB: patient's response to treatment\\nC: effectiveness of TTK inhibitors in the patient\\n\\nLogical Relations:\\n\\nDerived Implications:\\n\"}"
        ]
    }
}